Mineralys Therapeutics, Inc.
MLYSNASDAQ
USReal-Time Price
USReal-Time Price$21.58USD
+0.66 (+3.15%)Today
$21.58+0.00 (+0.00%)Pre-Market5:57 AM ET
BTI Score
Near Future
39
Long Term
43
BTI Fair Market Cap
$636.31M
+199.83% vs fair
Biotechnology
High Risk
Mineralys Therapeutics, Inc. (MLYS) Earnings
Mineralys Therapeutics, Inc. (MLYS) earnings: next report date, EPS and revenue consensus, historical surprises and the full quarterly results timeline.
Earnings Trends
Earnings Per Share
Revenue Beat Rate
N/A
Beat
0Meet
0Miss
0Total
0EPS Beat Rate
75%
Beat
3Meet
0Miss
1Total
4Earnings Consistency
0%
Both Beat
0Other
0Total
0Quarterly EPS Performance
Recent results and upcoming quarter
Q3 FY26
30 / 09 / 2026
Estimate—
Actual—
Surprise—
Q2 FY26
30 / 06 / 2026
Estimate$-0.55
Actual$-2.85
Surprise-422.3%
Q1 FY26
31 / 03 / 2026
Estimate$-0.47
Actual$-0.47
Surprise+0.1%
Q4 FY26
09 / 11 / 2026
Estimate$-0.55
Actual—
Surprise—
Revenue vs Earnings Over Time
Revenue (B USD)
Net Income (B USD)
Profit Margin (%)
EPS: Estimate vs Reported
Earnings History
| Quarter | EPS Est. | Reported EPS | Surprise | Rev. Est. | Reported Rev. | Date |
|---|---|---|---|---|---|---|
| Q3 FY26 | — | — | —▼ Miss | $0.00 | — | 30 / 09 / 2026 |
| Q2 FY26 | $-0.55 | $-2.85 | -422.3%▼ Miss | — | — | 30 / 06 / 2026 |
| Q1 FY26 | $-0.47 | $-0.47 | +0.1%▲ Beat | — | — | 31 / 03 / 2026 |
| Q4 FY25 | $-0.54 | $-0.40 | +26.4%▲ Beat | — | — | 31 / 12 / 2025 |
| Q3 FY25 | $-0.63 | $-0.52 | +17.8%▲ Beat | — | — | 30 / 09 / 2025 |
Source: FMP Earnings Calendar API. Surprise = (Actual − Estimate) / |Estimate| × 100.
MLYS upcoming earnings call
09 / 11 / 2026
ScheduledEPS Est: $-0.55